Aller au contenu

EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY ANNUAL CONGRESS (ESMO) 2021

16 Septembre 2021 · 6 joursOnline, FranceOncologyEnglish
EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY ANNUAL CONGRESS (ESMO) 2021
Online

About this congress

The ESMO Congress is the yearly appointment in Europe for nearly 30’000 clinicians, researchers, oncology nurses, patient advocates, journalists and representatives of the pharmaceutical industry from all over the world to get together, learn about the latest advances in oncology and translate science into better cancer patient care.

The ESMO 2021 programme will be developed by a committee composed of more than 300 international experts and will span from basic research to the latest discoveries in immunotherapy of cancer, form oncology nursing to palliative care, from rare cancers to approval of medicines.

Paris will be the home of the ESMO annual congress for the first time, taking place from 17 to 21 September 2021 at the Paris Expo Porte de Versailles, France.

MEDFLIXS couvrira les temps forts de ce congrès sous forme d'interviews vidéo et de best-of disponibles pour les professionnels de santé inscrits.

Vidéos de ce congrès

ESMO Congress 2021: Science
Play the video · ESMO Congress 2021: ScienceInscription gratuite requise pour lancer la lecture

00:00:30

Daniel  Catenacci · Personalized, neoantigen-directed immunotherapy in patients with advanced MSS-CRC, GEA and NSCLC
Play the video · Daniel Catenacci · Personalized, neoantigen-directed immunotherapy in patients with advanced MSS-CRC, GEA and NSCLCInscription gratuite requise pour lancer la lecture

Daniel Catenacci · 00:04:10

Daniel  Catenacci · MAHOGANY: margetuximab and retifanlimab in HER2+, 1L unresectable/metastatic GEA
Play the video · Daniel Catenacci · MAHOGANY: margetuximab and retifanlimab in HER2+, 1L unresectable/metastatic GEAInscription gratuite requise pour lancer la lecture

Daniel Catenacci · 00:04:09

Daniel  Catenacci · Gastroesophageal carcinoma with HER2 gene amplification
Play the video · Daniel Catenacci · Gastroesophageal carcinoma with HER2 gene amplificationInscription gratuite requise pour lancer la lecture

Daniel Catenacci · 00:01:42

Isabelle Ray-Coquard · Testing HRD in the clinic
Play the video · Isabelle Ray-Coquard · Testing HRD in the clinicInscription gratuite requise pour lancer la lecture

Isabelle Ray-Coquard · 00:01:18

Javier Garcia-Corbacho · CLIMB360: ctDNA-based molecular screening
Play the video · Javier Garcia-Corbacho · CLIMB360: ctDNA-based molecular screeningInscription gratuite requise pour lancer la lecture

Javier Garcia-Corbacho · 00:01:32

Icro Meattini · Impact of metastases-directed radiation therapy on CDK4/6 inhibitors treatment for mBC
Play the video · Icro Meattini · Impact of metastases-directed radiation therapy on CDK4/6 inhibitors treatment for mBCInscription gratuite requise pour lancer la lecture

Icro Meattini · 00:03:21

Roussos Torres · Combining epigenetic modulators and immune checkpoint blockade in cancer
Play the video · Roussos Torres · Combining epigenetic modulators and immune checkpoint blockade in cancerInscription gratuite requise pour lancer la lecture

Roussos Torres · 00:03:22

Roussos Torres · Entinostat, nivolumab and ipilimumab in advanced HER2-negative breast cancer
Play the video · Roussos Torres · Entinostat, nivolumab and ipilimumab in advanced HER2-negative breast cancerInscription gratuite requise pour lancer la lecture

Roussos Torres · 00:04:45

Nadia Harbeck · ELEANOR: real-world use of neratinib in HER2+, early breast cancer
Play the video · Nadia Harbeck · ELEANOR: real-world use of neratinib in HER2+, early breast cancerInscription gratuite requise pour lancer la lecture

Nadia Harbeck · 00:02:33

Nadia Harbeck · The impact of biomarkers on pCR and survival in WSG ADAPT TP
Play the video · Nadia Harbeck · The impact of biomarkers on pCR and survival in WSG ADAPT TPInscription gratuite requise pour lancer la lecture

Nadia Harbeck · 00:04:54

Peter Schmid · BARBICAN: ipatasertib plus atezolizumab and chemotherapy in TNBC
Play the video · Peter Schmid · BARBICAN: ipatasertib plus atezolizumab and chemotherapy in TNBCInscription gratuite requise pour lancer la lecture

Peter Schmid · 00:03:44